Neuraxis, Inc. NRXS

7.56 (0.19) (2.45%) as of 25 Sep
Market cap
$97.3M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
11.55 6.05 3.36 4.48 4.48 4.48
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(21.32) (9.25) (3.14) (19.23) (19.23) (19.23)
P/B ratio
12.14 7.88 0.00 0.00 0.00 0.00
EV/Sales
10.17 4.69 3.34 4.48 4.48 4.48
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(5.50) (2.03) (1.21) (5.03) (5.03) (5.03)
Current Ratio
2.05 1.75 0.13 0.07 0.34 2.44
Net Debt/EBITDA
0.64 0.53 0.05 0.08 (0.04) 0.39
Debt/Equity
0.00 0.00 0.00 0.00 (0.53) 0.19
ROE
(315.63%) (2,560.29%) 419.26% 149.37% (924.80%) 0.00%
ROA
(154.37%) (320.97%) (1,469.95%) (426.59%) (212.78%) 0.00%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(285.58%) (439.59%) 940.93% 74.54% 548.65% (245.89%)
Average Days of Receivables
20.01 33.24 10.86 23.71 15.46 58.87
Earnings Yield
(20.70%) (51.06%) (221.22%) (57.76%) (57.76%) (57.76%)
Free Cash Flow Yield
(16.02%) (38.24%) (82.50%) (19.86%) (19.86%) (19.86%)
Free Cash Flow per Share
(0.72) (0.89) (2.08) (1.18) (0.36) (0.67)
Book value per Share
0.37 0.30 (0.43) (2.78) (0.13) 0.27
Free Cash Flow
(6.56) (6.13) (6.77) (2.36) (2.23) (4.14)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates